BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3152844)

  • 1. [Determination of serum fructosamine as a parameter of metabolic control in type 2 diabetes mellitus].
    Cucinotta D; Lasco A; Di Cesare E; Perdichizzi G; De Leo A; Squadrito G
    Ann Ital Med Int; 1988; 3(2):132-6. PubMed ID: 3152844
    [No Abstract]   [Full Text] [Related]  

  • 2. [Variation of the fructosamine test in the determination of the concentration of nonenzymatic glucose bound to serum proteins by reference to the protein concentration and the use of a protein standard].
    Krantz S; Lober S; Lober M
    Z Med Lab Diagn; 1988; 29(7):387-9. PubMed ID: 3218297
    [No Abstract]   [Full Text] [Related]  

  • 3. [Longitudinal study of the concentration of serum fructosamine in diabetic patients (type 1 and type 2)].
    Fernandes F; Neto I; Pinto C; Parreira J; André O; Lisboa P; Azevedo M; Manso C
    Acta Med Port; 1986; 7(5-6):189-91. PubMed ID: 3630769
    [No Abstract]   [Full Text] [Related]  

  • 4. Fructosamine in a diabetic clinic.
    Baker J; Cutfield R; Taylor W
    N Z Med J; 1987 Dec; 100(837):733-5. PubMed ID: 3452178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fructosamine as a possible monitoring parameter in non-insulin dependent diabetes mellitus patients with periodontal disease.
    Unal T; Firatli E; Sivas A; Meric H; Oz H
    J Periodontol; 1993 Mar; 64(3):191-4. PubMed ID: 8463941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Should the assay of fructosamine be part of the elements of diabetic monitoring?].
    Maugendre D; Dezier JF; le Treut A; Allannic H
    Diabete Metab; 1990; 16(1):55-8. PubMed ID: 2185057
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of the determination of serum fructosamine in the screening of glucose intolerance].
    Ben Rayana MC; Aoun K; Achour A; Zouaghi H
    Ann Biol Clin (Paris); 1994; 52(5):389-90. PubMed ID: 7856941
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fructosamine determination as a tool in the prognosis of diabetes mellitus in dogs].
    Staudacher G
    Berl Munch Tierarztl Wochenschr; 1995 Nov; 108(11):418-20. PubMed ID: 8593134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fructosamine levels as an indicator of the glycosylation of serum proteins in diabetes mellitus type 1: clinical significance].
    Podgórski G; Czech A; Tatoń J; Laz R
    Pol Tyg Lek; 1987 Dec; 42(50):1581-4. PubMed ID: 3452802
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum fructosamine studies in pediatric diabetology].
    Acsai L; Szoboszlay I; Petheö I
    Orv Hetil; 1989 Oct; 130(40):2147-50. PubMed ID: 2694056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nifedipine on glucose tolerance, serum insulin, and serum fructosamine in diabetic and nondiabetic patients.
    Gill JS; Al-Hussary N; Zezulka AV; Pasi KJ; Atkins TW; Beevers DG
    Clin Ther; 1987; 9(3):304-10. PubMed ID: 3300989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [N-acetyl-beta-D-glucosaminidase activity in relation to blood glucose, serum fructosamine and type I diabetic nephropathy].
    Pinto C; Fernandes F; Marques C; Silva A; Azevedo M; Lisboa P; Manso C
    Acta Med Port; 1985; 6(3-4):97-102. PubMed ID: 4025000
    [No Abstract]   [Full Text] [Related]  

  • 13. [Measurement of plasma fructosamine in children with insulin-dependent diabetes mellitus].
    Hirai M; Kobayashi N; Shimojo N; Naka K; Yoshikawa C; Okuda K; Aono S
    Rinsho Byori; 1988 Aug; 36(8):939-42. PubMed ID: 3071634
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of fasting blood glucose and serum fructosamine levels for the assessment of glucose regulation in patients with non-insulin dependent diabetes mellitus].
    van Haeften TW; Walstra SM; Rustemeijer C
    Ned Tijdschr Geneeskd; 1989 Nov; 133(47):2356-7. PubMed ID: 2586671
    [No Abstract]   [Full Text] [Related]  

  • 15. [Practical value of serum fructosamine determination in diabetes mellitus].
    Pátkay J; Inkei J; Biró A; Berki A; Bereczki Z
    Orv Hetil; 1985 Dec; 126(51):3147-8, 3151-2. PubMed ID: 4080376
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of glycemic control in type 2 diabetic patients with diabetes-related dyslipidemia.
    Abdel-Gayoum AG
    Saudi Med J; 2004 Feb; 25(2):207-11. PubMed ID: 14968220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum fructosamine after death.
    Maruna P; Skrha J; Strejc P
    Diabet Med; 1989 Jul; 6(5):460. PubMed ID: 2527690
    [No Abstract]   [Full Text] [Related]  

  • 18. Fructosamine measurement.
    Jury DR; Dunn PJ
    Diabet Med; 1992 Mar; 9(2):206. PubMed ID: 1563257
    [No Abstract]   [Full Text] [Related]  

  • 19. Current state of metabolic control achieved in a New Zealand diabetes clinic.
    Dunn PJ
    N Z Med J; 1996 Mar; 109(1018):98-101. PubMed ID: 8606845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of serum fructosamine from capillary blood samples.
    Ricciotti R; Boemi M; Romagnoli F; Amadio L; Testa I; Fumelli P
    Acta Diabetol Lat; 1991; 28(1):115-7. PubMed ID: 1862687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.